ReutersSanofi’s Dengue Vaccine Candidate Shows Efficacy Against Dengue Fever In AsiaNASDAQ(RTTNews.com) – French drug maker Sanofi’s (SNYNF, SNY) Sanofi Pasteur division Friday announced the publication in The Lancet of the detailed results of its first landmark phase III dengue vaccine efficacy study conducted in five countries in Asia.Developing dengue vaccine shows 88% successFree Malaysia TodaySanofi dengue vaccine promising but questions remainReutersDeveloping dengue vaccine shows 88.5% successTimes of IndiaBBC News -Rappler -Voice of Americaall 63 news articles …Read Full Story
Sanofi's Dengue Vaccine Candidate Shows Efficacy Against Dengue Fever In Asia - NASDAQ
Real Estate of Cebu
